In this review, we address recent advances made in pathway engineering, directed evolution, and systems/ synthetic biology approaches employed in the production and modification of flavonoids from microbial cells. The review is divided into two major parts. In the first, various metabolic engineering and system/synthetic biology approaches used for production of flavonoids and derivatives are discussed broadly. All the manipulations/ engineering accomplished on the microorganisms since 2000 are described in detail along with the biosynthetic pathway enzymes, their sources, structures of the compounds, and yield of each product. In the second part of the review, post-modifications of flavonoids by four major reactions, namely glycosylations, methylations, hydroxylations and prenylations using recombinant strains are described.
Introduction
Flavonoids are natural pigments abundantly present in the plant kingdom. Structurally, they have the C 6 -C 3 -C 6 carbon framework. The position of linkage of B-ring to the C-ring (benzopyrano moiety) is used to sort these C-15 molecules into three different classes: flavonoids, isoflavonoids and neoflavonoids (Fig. 1) . Based on the degree of oxidation and saturation level in the C-ring and the presence of additional rings, flavonoids are divided into eight different subclasses. Isoflavonoids also contain several different subclasses and neoflavonoids comprise only Fig. 1 . Structures of different subclasses of flavonoids, isoflavonoids, neoflavonoids, and other minor flavonoids. Colors are used to differentiate each compound from another. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) three groups. Other plant secondary metabolites containing a similar carbon skeleton, such as chalcones, stilbenes, or aurones are considered minor flavonoids. The representative structures and example of each subclass of flavonoids are presented in Fig. 1 and Table 1.
Biosynthesis of flavonoids in plants
Flavonoids are biosynthesized on the cytosolic face of endoplasmic reticulum membranes by the action of various biosynthetic enzyme complexes. All these groups of compounds are derived from the phenylpropanoid pathway using three molecules of malonyl-CoA and a molecule of phenylpropanoyl-CoA. Except minor flavonoids, all others are biosynthesized via a common core unit, chalcone. Different classes of enzymes (isomerase, hydroxylase, oxido-reductase, post modification enzymes like glycosyltransferases, methyltransferases, acyltransferases) act on this core unit to diversify these molecules into the more than 8000 known flavonoids (Veitch and Grayer, 2011; Iwashina, 2015) and approximately the 2000 known isoflavonoids (Veitch, 2007) .
The flavonoid biosynthetic pathway is one of the most studied in plants and the enzymes involved are well characterized (Winkel-Shirley, 2006; Pandey and Sohng, 2013) . L-Phenylalanine or L-tyrosine produced via shikimate and aerogenate pathways are the starting precursors of the phenylpropanoid pathway. Tyrosine ammonia lyase (TAL) or phenylalanine ammonia lyase (PAL) converts tyrosine or phenylalanine to their carboxylic acid derivatives, p-coumaric acid and cinnamic acid, respectively. The conversion of cinnamic acid to p-coumaric acid requires an additional enzyme, cinnamic acid 4-hydroxylase (C4H). Using one molecule of adenosine triphosphate (ATP) and one molecule of coenzyme-A (CoA), 4-coumaroyl-CoA ligase (4CL) converts p-coumaric acid into activated 4-coumaroyl-CoA, one of the precursors in C6-C3-C6 backbone biosynthesis of different flavonoid classes. Another precursor is malonyl-CoA, mainly produced via acetyl-CoA by the irreversible action of acetyl-CoA carboxylase (ACC) complex. Three molecules of malonyl-CoA and a molecule of 4-coumaroyl-CoA are condensed by the action of chalcone synthase (CHS) to form a C6-C3-C6 backbone unit (naringenin chalcone) in all flavonoids. Naringenin chalcone is converted into naringenin in a ring-closing step by chalcone isomerase (CHI), which is further modified to various sub-classes of flavonoids and isoflavonoids (Fig. 2) . The same chalcone derivative is also converted to aurones by the constitutive action of various enzymes. For example, aurosedin synthase catalyzes the hydroxylation and/or oxidative cyclization of chalcones to aurones (Nakayama et al., 2000 (Nakayama et al., , 2001 Ono et al., 2006) and glucosyltransferases further modify aurones to their respective glucosides (Ono et al., 2006) . In contrast, stilbenoids are synthesized by using 4-coumaroyl-CoA and malonyl-CoA in a single step condensation reaction catalyzed by stilbene synthase (STS) and circumvents the chalcone intermediate. All these aglycone molecules are further diversified by various post-modification enzymes such as methyltransferases, glycosyltransferases, hydroxylases, acyltransferases etc. .
Significance of flavonoids in human health
In plants, flavonoids act against various biotic and abiotic stresses such as ultraviolet radiation, microbial infections, and physical and radical damage (Winkel-Shirley, 2002; Treutter, 2006) . In humans, flavonoids enter the body through consumption of plant-derived foods and play crucial roles in preventing the onset of various diseases (Williams et al., 2004) . For example, flavonoids scavenge free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated into the body and inhibit damage and propagation through metal chelation (Heim et al., 2002) . Free radical species cause cardiovascular diseases and neurodegenerative diseases like Parkinson's and Alzheimer's diseases. Moreover, studies found that flavonoids also play roles in the prevention and onset of cancers and diabetes (Ding et al., 2013; Xiao and Shao, 2013; Xiao and Tundis, 2013) .
Some of the specific biological functions of widely studied flavonoids and their therapeutic effects are summarized in Table 2 . Recently, flavonoids having antibacterial activities are attracting attention for the development of novel drugs or the adjuncts (Ozçelik et al., 2006 (Ozçelik et al., , 2008 Orhan et al., 2010; Pistelli and Giorgi, 2012; Kumar and Pandey, 2013; Moghaddam et al., 2014) . As a result, many researches are focused on production of natural as well as novel flavonoid derivatives using recombinant microorganisms by following various metabolic and protein engineering and synthetic biology approaches. These advances will be discussed in this article.
Metabolic engineering of microbes for flavonoids production
From long ago, humans have used microorganisms to supply foods, beverages, drugs and chemicals. But recently, development of metabolic engineering tools including genome sequencing and synthesis, protein engineering, computational system biology, and synthetic biology tools have enabled biotechnologists to generate robust microbial cell factories to produce wide range of natural and non-natural primary and secondary metabolites, commodity chemicals and biofuels (Ajikumar et al., 2010; Choi and Lee, 2013; Heider et al., 2014; George et al., 2015; Na et al., 2013; Rodrigues et al., 2015; Westfall et al., 2012) . Such advances have been extensively reviewed (Mora-Pale et al., 2014; Trantas et al., 2015; Wang et al., 2016; Xu et al., 2013a) . Flavonoids are secondary plant metabolites that have been the target of metabolic engineers for 10 to 15 years. To date, a number of groups have successfully produced and modified flavonoids from microbial sources such as Escherichia coli, Saccharomyces cerevisiae, and Streptomyces species (Fig. 3) . Although, the structural diversity of flavonoid group of compounds is very high in nature (Wang et al., 2011a) , development and production of novel and biologically potent flavonoids from . Because of the well-known genetics, easy manipulation of chromosome, high cell growth rate, and easy handling of E. coli, S. cerevisiae, and Streptomyces venezuelae, these organisms are extensively used in industry for the production of various chemicals and compounds. However, many hurdles of using microbial cells for the production of plant or microbial derived complex molecules remain to be addressed (Mora-Pale et al., 2013) . For example, many plant enzymes are difficult to express in prokaryotic microbes, such as E. coli because they are associated with plant cell organelles that are absent from simple prokaryotes. In such cases, lower eukaryotes, such as S. cerevisiae, have been employed for the production of complex secondary metabolites, such as metabolites produced in actinomycetes (Paddon et al., 2013) .
Flavonoids are low molecular weight compounds with a simple 15 carbon backbone. They are mainly synthesized in plants and as such, microorganisms like E. coli and S. cerevisiae do not include endogenous genes for their biosynthesis. Flavanones, such as naringenin, are the major intermediates in flavonoid biosynthesis and much research has focused on their production in engineered microbial cells (Wu et al., 2014a) . For fifteen years, various approaches have been developed and used to produce flavonoids and their derivatives from microorganisms. However, excluding a few exceptional cases, the volumetric production achieved is much lower than what is necessary to make the resulting process industrially relevant and commercially viable. Herein, we discuss the recent advancements made on the biosynthesis of flavonoids using genetically tractable microorganisms by metabolic engineering approaches. Particularly, pathway engineering, use of alternative enzymes from different sources, directed evolution, systems and synthetic biology approaches used for the production and modifications of flavonoids using microbial cells (Fig. 3) are the major interest of this review.
De novo pathway engineering
More than a decade ago, Horinouchi and colleagues assembled three genes specific for plant flavanone production: RrPAL from Rhodotorula rubra, ScCCL from Streptomyces coelicolor A3(2), and GeCHS from Glycyrrhiza echinata. The number of T 7 promoter and ribosome binding sites (RBS) in front of each gene was varied (Hwang et al., 2003) . The recombinant E. coli strains containing artificial gene cluster produced two flavanones namely pinocembrin and naringenin from phenylalanine and tyrosine, respectively. Ro and Douglas expressed putative plant phenylpropanoid pathway genes PAL, C4H, and the C4H redox partner cytochrome P450 reductase (CPR) from Populus trichocarpa × Populus deltoides to S. cerevisiae to study the carbon-flux from phenylalanine to p-coumaric acid (Ro and Douglasm, 2004) . A more extended recombinant pathway was used by Koffas and colleagues that included a C4H from Arabidopsis thaliana, a 4CL from Petroselinum crispum, and a CHS and a CHI from Petunia hybrida. By feeding with cinnamic acid, p-coumaric acid and caffeic acid, three different flavanones, namely pinocembrin, naringenin and eriodictyol were produced (Yan et al., 2005b Phenylalanine and tyrosine are produced via shikimate pathway in plastid. PAL and TAL convert L-phenylalanine and Ltyrosine to (E)-cinnamic acid and p-coumaric acid respectively. C4H and CPR also act on (E)-cinnamic acid to p-coumaric acid. 4CL activates phenylpropanoic acids to respective phenylpropanoyl-CoAs which enters to cytosol and undergoes condensation with three molecules of malonyl-CoA to produce naringenin chalcone. CHI further converts naringenin chalcone to naringenin, one of the major intermediates of flavones, flavonols, anthocyanidins, isoflavonoids, phlobaphenes by the action of various enzymes. Abbreviations of enzymes: PAL: phenyl ammonia lyase; TAL: tyrosine ammonia lyase; C4H: cinnamic acid 4-hydroxylase; CPR: cytochrome P450 reductase; 4CL: p-coumaroyl-CoA ligase; STS: stilbene synthase; CHS: chalcone synthase; CHI: chalcone isomerase; FS: flavone synthase; DFR: dihydroflavonol reductase; FLS: flavonol synthase; IFS: isoflavone synthase; and ANS: anthocyanidin synthase.
partial flavonoid and isoflavonoid biosynthetic pathways in S. cerevisiae for production of respective compounds. These studies of heterologous expression of plant phenylpropanoid pathway genes and flavonoid modification genes into E. coli and S. cerevisiae became the first platforms for the biosynthesis of various flavonoids and related compounds. Since then, heterologous biosynthesis of flavonoids using microbial cells has attracted significant interest around the globe for production in practical quantities. Torkin et al. (2005) Genistein Reducing the incidence of carcinogen-induced adenocarcinoma and cancer progression suppressing tumor growth and metastatic transition. Triggers cell death via activation of caspase-3/9 reaction oxygen species increases significantly. Hörmann et al. (2012) ; Kim et al. (2014) ; Song et al. (2015) Resveratrol Effects on cancer related transcription factors (p53), cell cycle regulation and induction of apoptosis (G2 and S phases), cell differentiation and proliferation (inhibition of mitogen-activated protein kinases, activator protein-1, nuclear factor (NF)ҡB) Baur and Sinchair (2006); Catalgol et al. (2012) Anti-inflammatory Hesperedin Suppression of inflammatory response induced by A. hydrophila toxins through down modulation of reaction oxygen species production other factors stimulation. Inhibit TNF-α production, NF-ƙB activation Ribeiro et al. (2015) Kaempferol Inhibit the production of COX-2, PGE2, and MMP-1 and MMP-3 Genistein Tyrosine kinase inhibitor, inhibition of NF-ƙB activation following AMP activated protein kinase stimulation connected with metabolic syndrome disease.
Cardioprotective Hesperedin Upregulation of protein levels of nuclear factor erythroid 2-related factor 2, which is responsible for antioxidant activity. 
Parkinson's disease 7,8-dihydro-xyflavone TrkB provokes its dimerization and auto phosphorylation and activates downstream signaling cascade, induce BDNF-like behavioral phenotypes Devi and Ohno (2012) Anti-viral Apigenin Inhibition of viral post entry stage of foot-and-mouth disease viral infection. Inhibition of hepatitis C virus replication by decreasing mature microRNA122 levels. Shibata et al. (2014); Qian et al. (2015) Respiratory disease Hesperedin Kaempferol-3-O-rhamnoside
Hesperidin reduces the Th2 cytokines (IL-5), eotaxin, ovalbumin-specific IgE production, and eosinophil infiltration via inhibition of GATA-3 transcription factor. Inhibit expression of INK4α in human dermal fibroblasts, down regulation of Ras-GRF1, RAC3 and UBE2D3 Chrysin Prevent age-associated memory loss by free radical scavenger action and modulation of BDNF of central nervous system. Souza et al. (2015) Abbreviations: AMP: Adenosine monophosphate; BDNF: brain derived necrosis factor; COX-2: cyclooxygenase; GATA3: trans-acting T-cell-specific transcription factor; GRF1: guanine nucleotide-releasing factor 1; HER2: human epidermal growth factor 2; IL: interleukin; INK: cyclin-dependent kinase; MMP: matrix metalloproteinase; mTOR: mechanistic target of rapamycin; NOD2: nucleotide-binding oligomerization domain-containing protein 2; PGE2: prostaglandin E2; PKC: protein kinase C; Ras-GRF1:Ras protein-specific guanine nucleotide-releasing factor 1; RAC3: Ras-related C3 botulinum toxin substrate 3; RIP2: receptor-interacting protein kinase 2; STAT3: signal transducer and activator of transcription 3; TNFR1: tumor necrosis factor receptor 1; UBE2D3: ubiquitin-conjugating enzyme E2 D3; VSMC: vascular smooth muscle cell.
Soon after the heterologous expression of phenylpropanoid pathway genes in S. cerevisiae and E. coli, de novo production of flavonoids using cheap carbon sources such as glucose and amino acids was explored. Watts and colleagues in 2004 constructed a recombinant E. coli host harboring TAL from Rba. capsulatus; 4CL and CHS from Arabidopsis thaliana and produced 20.8 mg L − 1 of naringenin without supplementing any precursor in the medium (Watts et al., 2004) . In another similar study, S. cerevisiae was engineered to produce naringenin and pinocembrin without addition of precursors in the medium. Overexpression of PAL from Rhodosporidium toruloides also exhibited TAL activity (L-phenylalnine (K m = 0.29 mM) L-tyrosine (K m = 0.18 mM)), At4CL1 from A. thaliana accepting different propanoic acids such as p-coumaric acid, ferulic acid, and caffeic acid as substrates, and CHS from Hypericum androsaemum in phenylacrylic acid decarboxylase encoding pad1 gene (decarboxylates trans-cinnamic acid and p-coumaric acid to their corresponding vinyl derivatives) knocked out strain of S. cerevisiae/Δpad1 produced 7 mg L − 1 of naringenin and 0.8 mg L − 1 of pinocembrin. Negligible amounts of 2′,4′,6′-trihydroxydihydrochalcone and phloretin were also detected as by products (Jiang et al., 2005) . The production titer of both naringenin and pinocembrin was enhanced to approximately 60 mg L − 1 in E. coli by expressing malonyl-CoA pool enhancing genes and supplementing amino acid precursors in the medium. Additional introduction of acetyl-CoA carboxylase (ACC) subunit genes (accBC and dtsR1) from Corynebacterium glutamicum in E. coli expressing the same set of flavonoid biosynthetic pathway genes used by Hwang et al., 2003 and addition of Pueraria lobata (PlCHI) produced 57 mg L −1 of naringenin and 58 mg L −1 of pinocembrin in the presence of 3 mM of tyrosine and phenylalanine in the medium (Miyahisa et al., 2005) . In an effort to expand the repertoire of flavonoid molecules produced, Leonard et al. reported the construction of S.cerevisiae recombinant strains for the production of plant specific flavone molecules. Specifically, the authors introduced a soluble flavone synthase I (PcFSI) from parsley and an insoluble (membrane bound P450 monoxygenase) flavone synthase II (AFNS2) from snapdragon into the previously constructed, flavanone producing S. cerevisiae recombinant strain. The resulting recombinant strains were able to convert various phenylpropanoid acid precursors into the flavanone molecules chrysin, apigenin and luteolin. Improvement of flavone biosynthesis was achieved by overexpressing the yeast P450 reductase CPR1 in the AFNS2-expressing recombinant strain; however, the recombinant yeast strain expressing the soluble PcFSI was the one that demonstrated Fig. 3 . Engineering approaches used for the heterologous production of flavonoids from different microbes. The sources of genes for flavonoid backbone synthesis could be plant, yeast or actinomycetes which is assembled in the platform organisms like E. coli, S. cerevisiae, or S. venezuelae using various approaches.
the highest production of flavones Leonard et al., 2005) , with final titers in the order of 2-3 mg L − 1 of apigenin and luteolin. The same group also tested the production of the same flavone molecules in recombinant E. coli that produces flavanones. Without any strain optimization, they demonstrated the production of the flavones apigenin at 0.4 mg L −1
, luteolin at 10 μg L −1 and genkwanin at 0.2 mg L −1 (Leonard et al., 2006a) . In a similar work in E. coli, the Horinouchi group also expanded the naringenin and pinocembrin producing systems to flavones and flavonols by expressing flavone synthase 1 (FS1) from P. crispum for flavones production and additional two genes flavanone 3β-hydroxylase (F3H) and flavonol synthase (FLS) from Citrus species for flavonols production. These flavone and flavonol producing strains produced 13 mg L − 1 of apigenin and 9.4 mg L − 1 of chrysin as flavones; 15.1 mg L − 1 of kaempferol and 1.1 mg L −1 of galangin as flavonols from tyrosine and phenylalanine, respectively (Miyahisa et al., 2006) . Flavonol production in recombinant E. coli was also demonstrated by Leonard et al. through the functional expression of a plant P450 flavonoid 3′,5′-hydroxylase (F3′5′H) as a fusion protein with a plant P450 reductase. By creating such a translational fusion, the authors mimiced the protein structure of the soluble bacterial P450s, such as the soluble BM3 P450 found in Bacillus megaterium. This allowed the production of the flavonols kaempferol and quercetin, albeit at small final titers (Leonard et al., 2006b) . In another study, in an effort to produce isoflavones in E. coli, the same team of investigators created a series of isoflavone synthases (the P450 monooxygenases that catalyze the conversion of precursor flavanones to isoflavones) that were truncated at their N-terminus which was replaced by tailor-made membrane recognition signals. The specific, in vivo production of isoflavones (specifically genistein) catalyzed by one of these artificial chimeras was up to 20-fold higher than that achieved by the native isoflavone synthase expressed in the eukaryote S. cerevisiae and up to 10-fold higher than the production achieved by soy beans . In another study, four metabolically engineered S. cerevisiae strains were generated by assembling flavonoid biosynthetic pathway genes from different sources. PAL and CPR from Populus hybrid (P. trichocarpa × P. deltoids), C4H, 4CL, CHS, CHI, isoflavone synthase (IFS), flavanone 3-hydroxylase (F3H), and flavonol 3′-hydroxylase (F3′H) from Glycine max, resveratrol synthase (RS) from Vitis vinifera cv. Soultanina, and FLS from Symphytum tuberosum were assembled in various combinations for production of stilbenes, flavanones, isoflavones, and flavonols. Each engineered strain was specific for production of a single compound from phenylalanine. The engineered strains produced 0.29 mg L −1 of trans-resveratrol, 8.9 mg L −1 of naringenin, 0.1 mg L −1 of genistein, 0.9 mg L −1 of kaempferol and 0.26 mg L −1 of quercetin under optimal growth conditions while supplementing 10 mM of phenylalanine in the medium. The production of the same compounds was higher (Table 3 ) upon supplementation of intermediates such as p-coumaric acid and naringenin (Trantas et al., 2009 ). In plants, the different isoforms of enzymes are hypothesized to be organized in one or more enzyme complexes to promote substrate channeling. Koopman and colleagues studied a subset of isoenzymes from A. thaliana by the Botany Array Resource (BAR) Expression Angler (Toufighi et al., 2005) for expression profile correlation analysis. Among several sets of genes included in the expression correlation studies, five flavonoid biosynthetic genes At4CL3, CHS1, CHI1, codon optimized C4H and PAL1, and two codon optimized CPR variants (CPR1 or CPR2) were used for naringenin biosynthesis in S. cerevisiae. The best assembled strain produced 1.47 mg L −1 of extracellular naringenin in shake-flask cultures containing synthetic medium and glucose as the sole carbon source. Engineering of strain by introducing tyrosine insensitive 3-deoxy-D-arabinose-heptulosonate-7-phosphate (DAHP) synthase ARO4 allele (ARO4 G226S ), knock-out of ARO3, and phenylpyruvate decarboxylase genes (PDC1, PDC5 and PDC6) enhanced the production of naringenin to 12.6 mg L −1 along with production of 200 μM of coumaric acid and phloretic acid as side products. Both byproducts were converted into naringenin by overexpression of additional copies of a codon optimized CHS3 and a yeast codon optimized TAL1 gene with known high catalytic efficiency from R. capsulatus, resulting in 54.45 mg L −1 of naringenin. Under controlled conditions in a 2-L fermenter, the strain produced 112.9 mg L − 1 of naringenin without addition of any precursor in the medium (Koopman et al., 2012) . De novo biosynthesis of other flavonoids from simple precursors includes anthocyanins (cyanidin 3-O-glucoside and pelargonidin 3-Oglucoside), flavan-3-ols ((+)-catechin and afzelechin), 5-deoxyflavanones (liquiritigenin), eriodictyol and resveratrol derivatives. Anthocyanins were produced by cloning a four step metabolic pathway that allowed the conversion of flavanone precursors into their corresponding anthocyanin molecules. The pathway included a flavanone 3-hydroxylase (F3H) from apple (Malus domestica) a dihydroflavonol reductase (DFR) from Anthurium andraeanum, an anthocyanidin synthase (ANS) also from apple and an anthocyanin 3-O-glucosyltransferase (3-GT) from Petunia hybrida. The selection of DFR and ANS was based on screening various plant enzymes from different plant sources recombinantly expressed in E. coli (Leonard et al., 2008a (Leonard et al., , 2008b . Two different anthocyanins, the purple cyanidin 3-Oglucoside and the orange pelargonidin 3-O-glucoside were produced by feeding the recombinant E. coli strain with their corresponding precursor flavanones, eriodictyol and naringenin, respectively, albeit at extremely low quantities of only a few micrograms per liter. Despite the low production, this was the first demonstration of the production of the unstable anthocyanins by a recombinant host and one of the first publications on recombinant production of flavonoid molecules (Yan et al., 2005a) . In another paper, Chemler et al. presented the production of flavan-3-ols, such as green tea catechins, in recombinant E. coli first from their flavanone precursors and then from their phenylpropanoic acid precursors. This was accomplished by contructing a recombinant pathway that included F3H from apple, DFR from A. andraeanum and leucoanthocyanin reductase (LAR) genes from Antirrhinum majus. While the production levels achieved were in the order of a few milligrams per liter, this was the first demonstration of the production of some rare catechins, such as afzelechin, in a recombinant host (Chemler et al., 2007a) . This production level was later increased to almost 1 g L −1 after extensive pathway engineering described later in this paper. In addition to the common flavanones, leguminous plants have evolved a distinct class of flavanone molecules known as 5-deoxyflavanones. Yan et al. constructed a four-step metabolic pathway in E. coli with 4CL derived from parsley, CHS from petunia and CHI and chalcone reductase (CHR) from the leguminous plant Medicago sativa. By optimizing feeding and fermentation strategies, the authors were able to reach a production of 17 mg L − 1 of liquiriteginin and 3.5 mg L −1 of isoliquiritigenin in the constructed recombinant strain.
By feeding with cinnamic and caffeic acids, other deoxyflavanones were also produced including 7-hydroxyflavanone (1.9 mg L ). The same pathway was also introduced in S. cerevisiae; however, the volumetric titers of the 5-deoxyflavanones produced were lower than the production achieved in E. coli (Yan et al., 2007) . In a later study, eriodictyol was produced from L-tyrosine in E. coli recombinant strain. Rhodotorula glutinis originated TAL, P. crispum originated 4CL, CHS from P. × hybrida, and CHI from M. sativa were used along with ACC complex genes (accBC, dtsR1 from C. glutamicum) and acs from E. coli to produce naringenin. Naringenin was further modified by hydroxylation using a fusion protein of truncated F3'H from Gerbera hybrida and CPR from Catharanthus roseus to eriodictyol. Upon modification of the host strain by deletion of acetate kinase (ackA) the resulting strain produced 5.70 mg L − 1 of ediodictyol from glucose. The production titer reached 107 mg L − 1 when sufficient L-tyrosine was exogenously supplemented and ACC complex genes were overexpressed in a high copy number plasmid . Similarly, in order to produce various precursors of flavonoids from simple carbon sources, Hong and his group constructed Phenylalanine R. rubra (PAL), S. coelicolor A3(2) (ScCCL), G. echinata (CHS), P. lobata (PlCHI), C. glutamicum (accBC and dtsR1) E. coli 57 58
Miyahisa et al. (2005) Apigenin Chrysin
15.6 Genistein Phenylalanine p-Coumaric acid Naringenin Kang et al. (2012) 3,5-dihydroxy 4′-methoxy stilbene 3,4'dimethoxy −5-hydroxy stilbene 3,5,4′-trimethoxy stilbene 
R. sphaeroides (Codon optimized RsTAL), fused protein of A. thaliana (At4CL) and V. vinifera (VvSTS)
S. cerevisiae 1.06 1.90
Yan et al. (2008) Cyanidin
Watts et al. (2006) 7-O-methyl aromadendrin Chrysin Apigenin Umar et al. (2012) (continued on next page) 9 (Kang et al., 2012 . The same group extended the pathway for methylated resveratrol production and assembled codon optimized S. espanaensis TAL, two O-methyltransferase (sbOMT1 and sbOMT3) genes from Sorghum bicolor, and a codon optimized STS from Arachis hypogaea (AhSTS), and ScCCL from S. coelicolor A3(2) in a monocistronic fashion under T 7 promoter. The recombinant E. coli produced resveratrol along with three methylated resveratrol deriva-
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), and 3,5,4′-trimethoxy stilbene (~0.05 mg L −1 )) from simple sugar . Moreover, introduction of an additional glycosyltransferase gene (yjiC) from Bacillus licheniformis DSM 13 (Pandey et al., , 2014c to the resveratrol biosynthesis monocistronic pathway produced resveratrol-4′-O-glucoside (7.5 mg L −1 ), trans-resveratrol-3-O-glucoside (trans-piceid) (2.5 mg L − 1 ), and cis-resveratrol-3-O-
) from glucose . Other examples of de novo biosynthesis of flavonoid derivatives from E. coli include methylated flavanones (sakuranetin, ponciretin) and kaempferol 3-O-rhamnoside (Fig. 4 ). Ahn and his group achieved successful production of flavonoid derivatives by engineering E. coli. To produce methylated flavanones from glucose, E. coli strain was mutated by disrupting three chromosomal genes (tyrR encoding for phenylalanine DNA-binding transcription repressor, pheA encoding prephenate dehydratase/chorismate mutase, and icdA encoding for isocitrate dehydrogenase) to divert carbon-flux towards L-tyrosine and CoA, two initial precursors of flavonoids. E. coli/ΔtyrRΔpheAΔicdA was further engineered by overexpressing genes encoding for phosphoenolpyruvate (ppsA), transketolase (tktA), feedback inhibitor insensitive deoxyphosphoheptonae aldolase (aroG fbr ) and prephenate dehydrogenase (tyrA fbr ) from E. coli along with heterologous flavonoid biosynthesis genes from different sources which included S. espanaensis (TAL), Oryza sativa (4CL), Populus euramericana (CHS), G. max (SOMT2) or O. sativa (NOMT). The engineered strains produced 42.5 mg L −1 of ponciretin and 40.1 mg L −1 of sakuranetin, respectively . The same background E. coli strain overexpressing same precursors enhancing genes and flavonoid biosynthesis genes (additional FLS from P. euramericana and AtUGT78D1 from A. thaliana in place of OMTs) produced 57 mg L −1 of kaempferol 3-O-rhamnoside .
Central carbon flux redirection
The supply of malonyl-CoA is considered as one of the major bottlenecks of biosynthesis of flavonoids. This precursor is required in the condensation reaction catalyzed by CHS, where three molecules of cytosolic malonyl-CoA are sequentially added to one molecule of phenylpropanoyl-CoA. Moreover, it is also one of the important precursors for biosynthesis of most polyketides and fatty acids. Thus, several efforts have been carried out to increase the pool of malonyl-CoA in microbial cytosol for the production of important polyketides, flavonoids, and long chain fatty acids. Malonyl-CoA pool availability has been enhanced in the cell by overexpression of ACC complex genes Wattanachaisaereekul et al., 2008) and knockout of ackA and acetaldehyde dehydrogenase (adhE) (Zha et al., 2009) (Fig. 4) . However, system biology approaches have been recently applied to design improved biocatalysts by analyzing genome-scale metabolic networks to identify minimal potential target genes for the enhanced production of malonyl-CoA and target secondary metabolites (Lim et al., 2011; Bhan et al., 2013a Bhan et al., , 2013b Xu et al., 2011) . This section discusses various strategies used for enhancement of malonyl-CoA and other cofactors pool necessary for the production of flavonoids and derivatives.
Malonyl-CoA biosynthesis genes, acetate assimilation genes, and malonate assimilation genes are mostly overexpressed to enhance the malonyl-CoA pool and thus flavonoids in many studies. Moreover, the malonyl-CoA and its precursors consuming pathway genes are also engineered to dam up the flow of malonyl-CoA and its precursors to other diverting pathways. Alternatively, orotic acid assimilation pathway and central uridine diphosphate (UDP)-glucose biosynthetic pathways are also engineered to enhance the biosynthesis of UDPglucose, the limiting cofactor in the biosynthesis of flavonoid glycosides (Fig. 4) . For example, ACC complex encoding genes (accABCD) along with biotin ligase (BirA) from Photorhabdus luminescens were expressed with acetate assimilation pathway genes (ackA, phosphotransacetylase (pta) and acetyl-CoA synthase (acs)) of E. coli. The engineered strain produced 429 mg L −1 of pinocembrin, 119 mg L −1 of naringenin, and 52 mg L −1 of eriodictyol which is 1379%, 183%, and 373% higher in comparison to the control strain overexpressing only flavonoid biosynthesis genes (Pc4CL2 from P. crispum, PhCHS from Petunia × hybrida and MsCHI from M. sativa) supplemented with cinnamic acid, p-coumaric acid and caffeic acid, respectively . In order to improve the biosynthesis of flavanones and anthocyanins, alternative carbon assimilation pathways were used along with plant biosynthetic genes and inhibition of competitive reaction pathways using chemical inhibitors.
Instead of overexpression of ACC complex for conversion of glucose to malonyl-CoA via acetyl-CoA, matB and matC from Rhizobium trifolii along with Pc4CL2, PhCHS, and MsCHI were used for the production of various flavanones from exogenously added phenylpropanoic acids, glucose, and malonate. The introduction of malonate assimilation pathway increased by 250% the biosynthesis of natural flavanone. The exogenous supplement of malonate, a direct source of endogenous malonylCoA and overexpression of malonate assimilation genes allowed the generation of malonyl-CoA bypassing central carbon metabolism. The malonyl-CoA in cell is primarily utilized in fatty acid metabolism. Thus, to circumvent the depletion of malonyl-CoA in the cell, fatty acid of eriodictyol which is more than 900% enhancement in production in comparison to control E. coli strain expressing only flavonoid biosynthetic pathway genes. High dose of cerulenin decreased production of flavonoids and also reduced the cell growth rate possibly due to the detrimental effect of malonyl-CoA on cell growth (Subrahmanyam and Cronan, 1998) . Thus, systematic enhancement of malonyl-CoA precursor is vital for increased production of flavonoids in E. coli. On the other hand, orotic acid assimilation pathway was also overexpressed for efficient biosynthesis of cyanidin 3-O-glucoside, an anthocyanin whose biosynthesis requires a glycosyltransferase that transfers the glucose moiety from UDP-glucose to the aglycone flavylium cation (anthocyanidin). Intracellular availability of UDP-glucose has been shown to be the limiting factor in the biosynthesis of anthocyanins in recombinant E. coli. Hence, to produce various anthocyanins from flavan-3-ol precursors (afzelechin, (+)-catechin), anthocyanin synthase (ANS) from P. hybrida and 3-O-glucosyltransferase (3-GT) from A. thaliana were overexpressed along with orotic acid assimilation genes (pyrE, pyrF, cmk, ndk). In addition, the E. coli glucose-1-phosphate biosynthetic gene phospho-glucomutase (pgm) and the E. coli glucose-1-phosphate uridylyltransdferase (galU) that are required for the synthesis of UDP-glucose were also overexpressed while the UDP-glucose utilizing pathway genes udg, galE and galT were deleted. The best strain produced up to 104 mg L − 1 of cyanidin 3-O-glucoside and 113 mg L − 1 of pelargonidin 3-O-glucoside from exogenous (+)-catechin and afzelechin, respectively (Leonard et al., 2008b) .
Alternative enzymes selection
Isoenzymes from different sources exhibit altered catalytic properties and therefore, proper selection of a gene from appropriate sources is a prerequisite for optimization of biosynthetic pathways for heterologous production of secondary metabolites. Since the flavonoid biosynthesis pathway is well studied in different plants, a number of phenylpropanoid pathway genes and flavonoid synthesis genes have been functionally characterized from different sources. Thus, studies have also been carried out where alternative flavonoid biosynthetic pathway genes have been assembled from different sources with the goal of higher production.
Koffas and his group in 2005 investigated the use of two different flavone synthase enzymes FSI (soluble) from P. crispum and FSII (membrane bound) from Antirrhinum majus cv. Montego Yellow for the production of flavones in S. cerevisiae. Previously characterized flavonoid biosynthetic genes C4H of A. thaliana, Pc4CL-2 from P. crispum, PhCHS and PhCHI from P. hybrida along with FSI or FSII harboring recombinant strains were generated. Functional FSII enzyme requires nicotinamide adenine dinucleotide phosphate (NADPH) and is inhibited by Fe 2+ while FSI requires 2-oxoglutarate, Fe
2+
, and ascorbate as cofactors. Supplementation of p-coumaric acid in the recombinant strains resulted in production of chrysin, apigenin, and luteolin as well as several of their precursors. However, comparative analysis showed 50% more apigenin production from FSI-expressing recombinant strain than FSII-expressing recombinant strain (Leonard et al., 2005) . Similarly, PhCHI was found to be rate limiting for biosynthesis of flavanones. Replacement of PhCHI by MsCHI from M. sativa resulted in enhanced production of pinocembrin, naringenin and eridictyol. In order to circumvent feedback inhibition issues, the BirA from P. luminescens instead of the E. coli BirA was overexpressed in order to enhance the biotinylation of acetyl-CoA carboxylase . In an effort to improve anthocyanin production, the same group reconstructed anthocyanin biosynthetic pathways in E. coli using genes from various plants and also diverted central carbon fluxes towards UDP-glucose. One of the key enzymatic steps in anthocyanin biosynthesis is the 2-oxoglutarate-dependent dioxygenase activitiy of ANS which utilizes ferrous iron and sodium ascorbate as cofactors. Thus, activity of ANS from different plant species was studied prior to producing anthocyanin from various precursors in E. coli. ANS from A. majus (AmANS), G. hybrida (GhANS), P. hybrida (PhANS), and Malus domestica (MdANS) were introduced in combination with A. thaliana GT (At3GT) to study the production of cyanidin 3-O-glucoside from exogenously added (+)-catechin, UDP-glucose and other necessary co-factors such as ammonium iron (II) sulfate and sodium ascorbate in the medium. Use of PhANS resulted in higher production of anthocyanin ) were produced from naringenin and eriodicyol, respectively. Later, enhanced production of anthocyanins was achieved by using flavan-3-ols as initial precursors, by creating a translational fusion between PhANS and At3GT, by engineering UDPglucose pathway (overexpression of pgm and galU) in E. coli, and by optimizing fermentation conditions such as pH, that greatly affect the stability of anthocyanins. The final titer of cyanidin 3-O-glucoside was 70.7 mg L −1 and pelargonidin 3-O-glucoside was 78.9 mg L −1 while feeding respective flavan-3-ol precursors (+)-catechin and afzelechin (Yan et al., 2008) . Similarly, for production of resveratrol from p-coumaric acid in E. coli, resveratrol biosynthesis pathway genes 4CL and STS from various sources were assembled in different combinations. Two 4CLs (At4CL1 and Pc4CL2) and eight STSs from seven different sources (Pinus strobus (PsSTS), Pinus massoniana (PmSTS), Pinus densiflora (PdSTS), Psilotum nudum (PnSTS), Polygonum cuspidatum STSs (Pcu1STS and Pcu3STS), V. vinifera (VvSTS) and A. hypogaea (AhSTS)) were used for the construction of recombinant E. coli strains. All strains were compared for the production of resveratrol under two different promoters (T7 and P GAP ) in two different background strains (E. coli BL21 star and E. coli BW27784). The combination of At4CL1 with VvSTS was found to result in the best resveratrol production when expressed in E. coli BW27784 strain in conjunction with overexpression of ACC/BirA and in the presence of cerulenin, a specific inhibitor of fabB-fabF gene products. The strain produced 2340 ± 90 mg L − 1 of resveratrol while feeding p-coumaric acid. The production of resveratrol expressing other STSs was significantly lower in comparison to VvSTS (Lim et al., 2011 ).
Stephanopoulos and his group also found that the use of enzymes derived from different sources is crucial for high level production of naringenin from glucose. E. coli recombinant strain exhibiting 90-fold to 160-fold higher catalytic efficiency for L-tyrosine over phenylalanine and harboring a Rhodobacter sphaeroides TAL (RsTAL/ hutH), a S. coelicolor 4CL-2 (ScCCL-2), an A. thaliana derived CHS (AtCHS), and a P. lobata originated codon-optimized PlCHI genes could not produce detectable amount of naringenin even when 500 mg L −1 of L-tyrosine was supplemented in the medium. Alternative selection of PhCHS from P. hybrida and MsCHI from M. sativa in place of AtCHS and PlCHI achieved 6 mg L −1 production of naringenin. The production further increased to 9 mg L −1 upon expression of both genes under constitutive promoter (P GAP ). Moreover, the combination of PhCHS and MsCHI with Ptrc-driven RgTAL derived from R. glutinis and P. crispus derived from Pc4CL-1 led to the production of 29 mg L −1 of naringenin. The overexpression of malonate assimilation pathway genes matB and matC from R. trifoli and supplementation of cerulenin resulted in naringenin production of 84 mg L −1 . In another study, the enzyme combinations from different sources were examined for production of catechins from flavanones. Biosynthesis of catechins from naringenin/ eriodictyol requires three enzymes: F3H a 2-oxoglutarate dependent dioxygenase that utilizes Fe 2+ and ascorbate as co-factors, and DFR and LAR that utilize NADPH as an electron donor. Three F3H-encoding genes (CsF3H from Camellia sinensis, MdF3H from M. domestica and PcF3H from P. crispum), three DFR genes (AaDFR from Anthurium andraeanum, CsDFR from C. sinensis, and FaDFR from Fragaria ananassa), and two LAR genes (CsLAR from C. sinensis and DuLAR from D. uncinatum) of different origins were codon optimized, modified, and synthesized to construct eighteen different pathway variants using the ePathBrick vectors (Xu et al., 2012; Xu and Koffas, 2013) . Among the 18 different combinations constructed, the recombinant strain expressing CsF3H-CsDFR-DuLAR exhibited maximum production of (+)-catechin (65.1 ± 0.9 mg L −1
) from 167 mg L −1 of exogenously added eriodictyol which was a 156% increase in production in comparison to previous report (Chemler et al., 2007a) . However, maximum (+)-afzelechin (39.5 ± 0.9 mg L − 1 ) was produced by the CsF3H-FaDFR-DuLAR combination which was very close to the titer (38.9 ± 1.6 mg L − 1 ) produced by CsF3H-AaDFR-DuLAR combination, revealing the significance of selection of alternative enzymes for the production of target compounds. The results also showed enhanced production of (+)-catechin (374.6 ± 43.6 mg L − 1 ) upon expression of two additional copies of each
CsDFR and DuLAR in CsF3H-CsDFR-DuLAR harboring plasmid. Since DFR and LAR require NADPH as a cofactor, an E. coli strain deficient in glucose-6-phosphate isomerase encoding pgi and phosphoenolpyruvate carboxylase encoding ppc genes which improve the intracellular NADPH pool enhanced (+)-catechin production to 760.9 ± 84.3 mg L − 1 ; however, this titer was achieved by using the CsF3H-AaDFR-DuLAR gene combination. Finally, by using a library of scaffolding proteins for pathway optimization, 910.9 mg L −1 of (+)-catechin was obtained from 1.0 g L −1 of eriodictyol in E. coli BLΔpgiΔppc mutant .
Protein engineering/mutagenesis
Site directed mutagenesis of proteins is usually carried out to identify the target catalytic amino acids of a protein. However, the alteration of the amino acid also generates novel enzyme mutants that can exhibit different catalytic efficiency while accepting different substrates for reaction. For example, unnatural polyketide scaffolds (Abe and Morita, 2010) , alkaloid scaffolds (Morita et al., 2012) , oleandomycin glycosides (Gantt et al., 2008) , and commodity small molecules have been synthesized by site directed mutagenesis of different enzymes. The protein engineering and mutagenesis has also been applied for improved flavonoid production efficiency from microbes. For example, three enzymatic steps of resveratrol biosynthesis were assembled in S. cerevisiae by introducing RsTAL from R. sphaeroides, At4CL from A. thaliana and VvSTS from V. vinifera. S. cerevisiae harboring At4CL and VvSTS produced 650 μg L −1 of extracellular resveratrol upon supplementation with p-coumaric acid. However, the translational fusion protein of At4CL and VvSTS, generated by replacing stop codon of At4CL by a three amino acid linker followed by VvSTS open reading frame enhanced resveratrol production to 5250 μg L −1
. The efficient channeling of intermediates between enzymes or two active sites is found to be crucial for high titer production of the final compound, and this titer of resveratrol was 3500-fold higher than the amount reported by Becker et al. (2003) . The use of yeast preferred codon-optimized RsTAL in conjunction with fused At4CL-VvSTS radically increased p-coumaric acid as well as resveratrol biosynthesis. Without adding L-tyrosine in the medium, the recombinant yeast produced 1.06 mg L −1 of resveratrol after 48 h of incubation, but production increased to 1.90 mg L −1 when L-tyrosine was added (Wang et al., 2011b) . Similarly, after selecting a combination of A. thaliana At3GT and P. hybrida PhANS from four different origins (A. majus (AmANS), G. hybrida (GhANS), P. hybrida (PhANS), and M. domestica (MdANS)) to optimize the conversion of (+)-catechin to cyanidin, two genes At3GT and PhANS were translationally fused, creating two different types of translational fusions between PhANS and At3GT depending on the order the two genes were placed next to each other. In the first module, PhANS was fused to the Nterminus of At3GT while in second module the order of the genes was reversed. Both enzymes were connected via a minilinker coding for Ser-Ser-Gly-Ser-Gly. The fusion protein having At3GT at Nterminus of PhANS exhibited improved activity and led to approximately 17% improvement in cyanidin 3-O-glucoside (45.5 mg L − 1 ) production compared to tandem expression (38.9 mg L − 1 ). Coexpression of fusion protein with galU and pgm resulted in 70.7 mg L −1 of cyanidin 3-O-glucoside and 78.9 mg L −1 of pelargonidin 3-O-glucoside from (+)-catechin and (+)-afzelechin, respectively (Yan et al., 2008) . Recently, wild type V. vinifera STS (WtVvSTS) variants were generated by homology modeling with previously resolved crystal structure of STS from A. hypogaea. WtVvSTS was able to accept various CATL and BYN-type pyrones (Abe et al., 2004; Morita et al., 2001 ). The specificity of VvSTS was further expanded by using varying sizes of starter precursors such as propionyl-CoA, myristoyl-CoA, octanoyl-CoA and methylmalonyl-CoA instead of natural malonylCoA. All starter precursors were accepted by WtVvSTS to produce various non-natural aromatic polyketides, however the mutant VvSTSs generated different polyketides from WtVvSTS using those aforementioned -CoAs coupled with malonyl-CoA as an extender unit (Bhan et al., 2015a (Bhan et al., , 2015b . These studies expanded the possibility of production of various kinds of natural and non-natural flavonoid molecules by mutagenesis of type III polyketide synthases.
Precursor directed synthesis of flavonoids
In general, chemical synthesis of flavonoid compounds is often complex and expensive because of multiple hazardous synthesis steps and low final yields. Therefore, precursor directed synthesis is an attractive alternative for creating both natural and non-natural flavonoid analogs from inexpensive starting materials and endogenous precursors and cofactors (Chemler et al., 2007b (Chemler et al., , 2010b Fowler et al., 2011; Horinouchi, 2008 Horinouchi, , 2009 Mora-Pale et al., 2013) .
Phenylpropanpoic acids and flavanone intermediates are the major precursors of flavonoids produced from plants (Figs. 2 and 4) . Therefore, these molecules are often exogenously supplemented to the engineered strains to produce different final compounds. In few experiments, unnatural flavonoid compounds have been synthesized by supplementing non-natural chemically synthesized phenylpropanoic acid precursors or flavanone derivatives. In some cases, precursor molecules that structurally do not resemble phenylpropanoic acids have also been accepted as initial precursor substrates by flavonoid biosynthetic enzymes to produce entirely different molecules (Bhan et al., 2015a) . A number of studies have been carried out to generate natural and novel flavonoid compounds by the approach discussed herein.
The four-step anthocyanin biosynthetic pathway consisting of MdF3H and MdANS from M. domestica, AaDFR from A. andraeanum, and UDP-glucose:flavonoid 3-O-glucosyltransferase (UGT3) from P. hybrida was introduced in E. coli to produce two anthocyanins, pelargonidin 3-O-glucoside (5.6 μg L ) from exogenously supplemented flavanones naringenin and eriodictyol, respectively. In this study, higher concentration of intermediates like dihydroflavonols and flavonols were found to accumulate in the fermentation broth (Yan et al., 2005a) . Similarly, two natural stilbene derivatives have been biosynthesized in practical amounts, resveratrol (104.5 ± 4.4 mg L −1 ) and piceatannol (13.3 ± 0.3 mg L − 1 ), by supplementing natural phenylpropanoic acid precursors (p-coumaric acid and caffeic acid, respectively) from recombinant E. coli harboring plant stilbene biosynthesis genes At4CL1 of A. thaliana and AhSTS of A. hypogaea (Watts et al., 2006) . In the same way, 7-O-methyl aromadendrin was produced from exogenously added p-coumaric acid precursor in recombinant E. coli harboring flavonoid pathway genes Pc4Cl2, PhCHS, MsCHI, AtF3H from different plant sources and a post modification gene 7-O-methyltransferase (SaOMT) from Streptomyces avermitilis. Introduction of ACC subunits, biotin ligase, and acetyl-CoA synthase genes from Nocardia farcinica resulted in the production of 2.7 mg L −1 of 7-O-methyl aromadendrin. When the precursor was naringenin, production was enhanced to 30 mg L −1 without any optimization of the malonyl-CoA availability (Malla et al., 2012) . Horinuchi and his group in 2007 designed E. coli based platforms for precursor-directed biosynthesis of various natural/unnatural flavonoids and stilbenoids. The flavonoid biosynthesis system was divided into three modules. First, the substrate synthesis step is catalyzed by Le4CL-1 from Lithospermum erythrohizon. Second, the polyketide synthesis step was catalyzed by either GeCHS from G. echinata for chalcone synthesis or PlCHI from P. lobata for flavanone synthesis, or AhSTS from A. hypogaea for stilbene synthesis. And third, the post-polyketide modification steps were catalyzed by FSI from P. crispum for flavones, and F3H and FLS from Citrus for flavonol synthesis. For increasing intracellular malonyl-CoA, two subunits of ACC (accBC) were also overexpressed from C. glutamicum. To these strains, 14 different chemically synthesized and naturally available carboxylic acid derivatives were fed to produce 87 different aromatic polyketides of which 36 were novel compounds including triketide and tetraketide pyrones (Fig. 5A) . The scaled up reactions using cinnamic acid, p-coumaric acid, fluorocinnamic acid, furyl and thienyl cinnamic acid as starter precursors resulted in the production of 70-90 mg L −1 of natural and 50-100 mg L −1 of synthetic flavanones. While the production of natural and synthetic pyrones was limited to 3.6 ± 1.1 mg L − 1 and 2.7 ± 0.8 mg L −1 , respectively, the production of flavones was reported in the range of 25 mg L −1 to 85 mg L −1 while flavonols were produced in lower amounts. The production of stilbenes by supplementing above mentioned starter units was in the range of 50-170 mg L −1 in comparison to other flavonoids (Katsuyama et al., 2007) .
Koffas and colleagues also produced synthetic flavanone and flavone derivatives by supplementing synthetic phenylpropanoic acid derivatives derivatized by fluoro and amino functional groups at various positions of the phenolic ring. In addition to natural phenylpropanoic acids, E. coli harboring flavanone and flavone biosynthesis genes were fed with (E) 2-fluoro-cinnamic acid, (E) 4-fluoro-cinnamic acid, (E) 2-cinnamic acid, (E) 3-cinnamic acid, and (E) 4-amino cinnamic acid. The flavanone producing strain generated pinocembrin, naringenin, eriodictyol, 5,7-dihydroxy-2′-fluoroflavanone, 5,7-dihydroxy-4′-fluoroflavanone, 5,7,2′-trihydroxyflavanone, 5,7,3′-trihydroxyflavanone, 4′-amino-5,7-dihydroxyflavanone whereas the flavone producing strain produced chrysin, apigenin, luteolin, 5,7-dihydroxy-2′-fluoroflavone, 5,7-dihydroxy-4′-fluoroflavone, 5,7,2′-trihydroxyflavone, and 4′-amino-5,7-dihydroxyflavone. The production titer of natural flavanones and flavones was considerably higher than synthetic derivatives (Leonard et al., 2008b) .
Similar to E. coli, biosynthesis of natural/synthetic flavonoids/ isoflavonoids has been successfully achieved in S. cerevisiae. By using a combinatorial biosynthesis approach, Koffas and his colleagues were able to produce diverse kinds of synthetic flavonoids from S. cerevisiae by engineering plant flavonoid biosynthetic genes 4CL, CHS, and CHI Fig. 5 . Biosynthesis of natural and unnatural flavonoids, isoflavonoids, and stilbenes using various starting precursors. A) Precursor directed synthesis of chalcones, flavanones, flavones, flavonols, and stilbenes using recombinant E. coli supplemented with 20 different natural/unnatural carboxylic acid precursors. B) Precursor directed synthesis of natural/unnatural isoflavone derivatives from chemically modified flavanones in recombinant S. cerevisiae. Genes used for cell engineering are described in the text. from various sources (Chemler et al., 2007b) . To the engineered strain, natural (p-coumaric acid, m-coumaric acid, o-coumaric acid) and chemically synthesized phenylpropanoic acids (p-fluorocinnamic acid, ofluorocinnamic acid, p-aminocinnamic acid) were supplemented exogenously. As a result, ( ) derivatives were produced. In addition, the recombinant flavanone biosynthetic pathway was also able to accept acrylic acid (trans, trans-muconic acid) to produce (2E)-[(2S)-5, 7-dihydroxy-4-chromanone] propenoic acid. Additional expression of F3H in the same S. cerevisiae produced dihydroflavonol derivatives of aforementioned flavanones in a similar production range (0.75 to 63 mg L −1 ) as flavanones (Chemler et al., 2007b) . Precursor directed biosynthesis of natural and unnatural isoflavonoids was also developed in S. cerevisiae by the same group using three enzymes IFS, CPR, and 2-hydroxyisoflavanone dehydratase (HID) from different plants. IFS encoding genes from five different plants were screened (G. max, Trifolium pretense, G. echinata, Pisum sativum, and Medicago truncatula) based on the production of genistein from naringenin. Finally, GmIFS and GmHID of G. max, and CrCPR of C. roseus harboring S. cerevisiae recombinant was used for the biotransformation of a variety of B ring modified flavanones which included 7 natural and 19 nonnatural hydroxyl, fluoro, chloro, bromo, methyl, methoxy, and ethoxy substituted flavanones (Fig. 5B) . Among them, seven flavanones were not accepted as substrates for biotransformation to isoflavones. However, altogether 20 different isoflavones were produced using the engineered S. cerevisiae strain (Chemler et al., 2010b) .
Besides E. coli and S. cerevisiae, one of the most commonly used hosts for production of various kinds of microbial polyketides is S. venezuelae. A strain deficient in pikromycin polyketide synthase was used as a heterologous host for production of flavonoids. A plasmid expressing ScCCL from S. coelicolor and AtCHS from A. thaliana was constructed and introduced into S. venezuelae. The resulting strain produced significantly small amounts of a racemic mixture of naringenin (0. of resveratrol and 0.6 mg L − 1 of pinosylvin from p-coumaric acid and cinnamic acid precursors, respectively (Park et al., 2009 ). The same group further engineered S. venezuelae by introducing codonoptimized F3H from C. siensis and FLS from Citri unshius. The strain produced kaempferol and galanin from flavanone precursors naringenin and pinocembrin, respectively (Park et al., 2010) . The integration of malonate assimilation pathway genes (matB and matC) in S. venezuelae genome and overexpression of flavanone (ScCCL, AtCHS, AtCHI) and flavone (ScCCL, AtCHS, AtCHI, and PcFS1) biosynthetic genes produced 35.6 mg L −1 of naringenin and 44.1 mg L −1 of eriodictyol as flavanones whereas 30.9 mg L −1 of chrysin and 15.3 mg L −1 of apigenin as flavones from p-coumaric acid and cinnamic acid (Park et al., 2011) . Finally, the biosynthesis of a novel, natural resveratrol dimer, resveratrol-trans-dihydrodimer, was recently reported through the use of a soybean peroxidase. The resveratrol-trans-dihydrodimer displayed antimicrobial activity against the Gram-positive bacteria Bacillus cereus, Listeria monocytogenes, and Staphylococcus aureus (minimum inhibitory concentration (MIC) = 15.0, 125, and 62.0 μM, respectively) and against Gram-negative E. coli (MIC = 123 μM, upon addition of the efflux pump inhibitor Phe-Arg-β-naphthylamide) (Mora-Pale et al., 2015).
System/Synthetic biology approaches
System biology encompasses the computational and mathematical modeling tools for biological systems that focus on complex interactions within a biological system (Herrgård et al., 2006; Stephanopoulos et al., 2004) . For example, the study of interactions between the components of a biological system such as enzymes and metabolites, or flux balance analysis for carbon and co-factors, to construct a model organism has become indispensable in metabolic engineering (Joyce and Palsson, 2008; Oberhardt et al., 2009) . Synthetic biology provides the tools that allow us to transplant the genes related to biosynthetic pathways from natural hosts into biotechnologically relevant hosts by precisely tuning and optimizing the gene expression in metabolic pathways. This is achieved by engineering molecular control elements in genetic device/vectors to accurately switch metabolic fluxes towards target pathway (Lee and Keasling, 2008; Young and Alper, 2010; Xu et al., 2012) . In one approach, synthetic antisense RNAs (asRNAs) is used to downregulate the expression of pathway specific genes and optimize the flux of interest (Yang et al., 2015a) . Design and construction of synthetic vectors and bio-parts for efficient cell factory development, innovative DNA assembly techniques for efficient assembly of combinatorial biosynthetic pathways simplify the major challenges of metabolic engineering for microbial production of natural products and commodity chemicals (Gibson et al., 2009; Jeong et al., 2012; Markham and Alper, 2015; Xu et al., 2012) . Both systems and synthetic biology accelerate the understanding of biological systems to engineer cells for novel functions. Under this subsection, we will focus on applications of system/ synthetic biology tools for improved production of flavonoids and derivatives.
Computational designing/modeling for cofactor/precursor enhancement
Because of cellular complexity and interconnectivity, the identification of genetic targets for modification for the purpose of redirecting metabolic fluxes is difficult to perform by simple metabolic pathway inspection. However, rapid advances in systems and synthetic biology aid in addressing this engineering conundrum (Stephanopoulos et al., 2004; Lanza et al., 2012) . A Cipher of Evolutionary Design (CiED) was developed based on the genetic algorithm and was used for strain design using a previously published E. coli metabolic model (EciJR904 GSM/GPR) (Reed et al., 2003) . This strain design method allowed the development of a new E. coli genotype with enhanced carbon flux towards malonyl-CoA and other cofactors. Based on the CiED algorithm, deletion of citrate cycle genes sdhCDAB encoding for succinate dehydrogenase and citrate lyase (citE), the amino acid transporter brnQ, and the pyruvate consuming enzyme acetaldehyde dehydrogenase (adhE), combined with overexpressions in the CoA and malonyl-CoA biosynthetic pathways, generated an efficient genotype for the production of flavanones. Among 11 engineered strains, E. coli strain (Z40NAC) deficient in sdhA, adhE, brnQ and citE genes harboring flavanone biosynthesis pathway genes (Pc4CL2, PhCHS, and MsCHI) and overexpression of cofactor and assimilation pathways (ACC complex and biotin ligase (BirA) from P. luminescens, coaA encoding for pantothenate kinase and acs from E. coli) produced 270 mg L −1 of naringenin and 150 mg L −1
of eriodictyol when feeding with p-coumaric acid and caffeic acid, respectively . Following production of flavanone by enhancing the malonyl-CoA pool in cell cytosol by using the CiED based E. coli model, the same tool was used to develop E. coli genotypes generating improved reduced NADPH. This strain was applied to leucoanthocyanidin and (+)-catechin biosynthesis in which NADPH serves as essential cofactor. Twenty-two E. coli strains deficient in a single and a combination of various genes were generated, and E. coli BL21 deficient in glucose-6-phosphate isomerase (pgi), phospholipase A or lysophospholipase L (pldA/B) and phosphoenolpyruvate carboxylase (ppc) resulted in production of 817 mg L −1 leucocyanidin while using DuLAR from D. uncinatum and supplementing 5 mM of ] ratio was found to be significantly improved in the E. coli BL/ΔpgiΔpldAΔppc strain and determined to be one of the superior strains for biosynthesis of compounds utilizing NADPH (Chemler et al., 2010a) . Similarly, the OptForce integrated computational approach was applied to design an E. coli BL21Star™ strain with improved flux towards malonyl-CoA. The great benefit of OptForce is that, in addition to deletions it can also identify targets for deletions and for downregulations. The knockout of fumerase encoding gene (fumC) and succinyl-CoA synthetase encoding gene (sucC) and overexpression of accABCD, phosphoglycerate kinase encoded by pgk, and pyruvate dehydrogenase complex encoded by aceEF and lpdA genes produced four-fold higher intracellular malonyl-CoA than wild type strain. The same strain upon expression of additional genes for naringenin biosynthesis (Pc4CL2, PhCHS and MsCHI) produced 474.2 mg L − 1 of naringenin from exogenously supplemented p-coumaric acid (Xu et al., 2011 ). The same model was also used for the production of 1.6 g/l of resveratrol by overexpressing A. thaliana At4CL-2 and V. vinifera VvSTS genes downstream of the gap promoter (P GAP ) (Bhan et al., 2013b) . These are the successful examples of applications of systems biology tools for flavonoid production. It is important to note that in addition to overexpressions and deletions, OptForce predicted a number of downregulations for improving flavanone production, such as the downregulation of fumB, fumC and acnA. Some of these downregulations, together with the downregulation of FadR (a transcription factor regulating fatty acid biosynthesis) were recently tested individually using CRISPRi/dCas9 and demonstrated the ability to increase flavanone production ).
Modular metabolic engineering
Metabolic engineering involves a series of genetic manipulations to increase the robustness of so-called "bio-factories". For the production of complex pharmaceuticals or nutraceuticals, long metabolic pathways are often involved. There are several cloning techniques to incorporate pathway specific genes to build a complete recombinant vector or integration of multiple genes into host chromosomes for production. However, these strategies are not sufficient in industrial biotechnology for targeted chemical/compounds production. Recently, modular metabolic engineering approach has been employed for production of various compounds like taxol (Ajikumar et al., 2010) , fatty acids , protein (Gu et al., 2015) , fuels and chemicals (Tseng and Prather, 2012) and many other compounds and commodities including flavonoids (Jones et al., , 2015b Cress et al., 2015b ). Wu and colleagues have made progress on flavonoid production enhancement by modular metabolic engineering of the flavonoid biosynthetic pathway. For example, the entire (2S) pinocembrin biosynthesis pathway genes from glucose were divided into four different modules. The first module produces phenylalanine from D-glucose and contains overexpression of 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase (DAHPS) aroF (E. coli K12) and feedback inhibition resistant chorismate mutase/ prephenate dehydratase (pheA fbr ). The second module produces cinnamoyl-CoA from L-phenylalanine and contains RgPAL (R. glutinis) and Pc4CL. The third module produces (2S) pinocembrin using PhCHS and MsCHI. The final module produces a pool of malonyl-CoA from malonate (matB and matC from R. trifolii). All genes were assembled under the T7 promoter in four different vectors with different copy numbers. Different combinations of the modules were tested for the optimum production of (2S)− pinocembrin by constructing four strains. The optimally balanced pathway produced 40.02 mg L −1 of final product from glucose without supplementation of precursors in the medium (Wu et al., 2013a) . Similarly, the coumaroyl-CoA producing module, malonyl-CoA generating module and (2S)-naringenin producing module were constructed by cloning the same set of (2S)-pinocembrin producing genes. RgTAL from R. glutinis exhibited the highest in vitro enzymatic activity towards L-tyrosine, and was selected instead of RgPAL. Pc4CL, PhCHS, MsCHI, matB and matC were assembled to construct synthetic flavonoid biosynthesis pathway in E. coli to produce (2S)-naringenin. Each module was assembled in plasmids with different copy numbers and promoter strengths (T7 or Ptrc). Different combinations of modules were assessed to identify an optimally balanced pathway. The optimal strain produced 90.59 mg L −1 of naringenin from Ltyrosine. Additional modules overexpressing feedback resistant genes DAHP synthase aroG fbr and tyrA fbr produced 100.64 mg L − 1 of naringenin from D-glucose, the highest production titer of naringenin in E. coli from D-glucose (Wu et al., 2014b) . Multivariate modular metabolic pathways were also constructed for resveratrol production from simple precursor like L-tyrosine. Efficient bioconversion of L-tyrosine to resveratrol is one of the rate limiting steps (Lim et al., 2011 ) a problem that has been partially addressed by engineering the resveratrol biosynthesis pathway using the multivariate modular engineering approach. More specifically, the resveratrol biosynthetic pathway was divided into three modules: the first module was the coumaroyl-CoA producing module containing RgTAL and Pc4CL, the second module was the resveratrol synthesis module containing VvSTS from V. vinifera and the third module was the malonyl-CoA producing module containing matB and matC. Each module was constructed under two different promoters having different strengths (T7 and Ptrc) in four different copy number plasmid backbones (pETDuet-1, pRSFDuet-1, pACYCDuet-1, and pCDFDuet-1). Eighteen different combinations of the three modules were checked for production of resveratrol from L-tyrosine. The best combination of the three modules (first module genes under Ptrc promoter in CDF origin of replication plasmid, second module under T7 promoter in pBR322 origin of replication plasmid backbone and third module under T7 promoter in p15A origin of replication containing plasmid) produced maximum of 35.02 mg L −1 of resveratrol (Wu et al., 2013b ).
Vector design
A series of genetic manipulation is required to balance metabolic flux in bacteria during flavonoid biosynthesis. Synthetic biology makes the control and manipulation of biological systems easier by constructing complex biological devices/vectors that allow the easy cloning of multiple genes involved in a biosynthetic pathway (Xu and Koffas, 2013) . Vectors are common tools to carry genetic materials into the host. Several essential features of a vector can be engineered, such as compatible origin of replication so that multiple vectors can be cotransformed in the same host strain, compatible vector/gene copy number of plasmid, promoter strength, and ribosome binding sites to ensure higher product titer (Ajikumar et al., 2010; Wu et al., 2013b) .
Synthetic vectors have been designed so that they allow the construction of artificial biosynthetic pathways for fine tuning and higher titer production of various flavonoids and their derivatives. The ePathBrick vector system has been developed for fine-tuning of gene expression and modular assembly of pathway genes and transcriptional components and has been applied for the enhanced production of the flavanone naringenin (Xu et al., 2012) . In this report, the pseudooperon gene structure (each pathway gene was under the control of an independent promoter while all mRNA transcripts shared the same terminator) consisting of the multigene pathway for naringenin biosynthesis (Pc4CL-PhCHS-MsCHI) and malonyl-CoA biosynthesis (accD-accCaccB-accA) led to the highest naringenin production from all gene configurations tested (36.7 mg L −1 without ACC complex encoding genes and~80 mg L −1 with ACC genes). Similarly, employing the same ePathBrick vector system, (+)-catechin was produced at a titer of 910.9 mg L − 1 from 1.0 g L − 1 of eriodictyol in batch culture . In another independent study, seven NDP-sugar biosynthesis pathway genes were cloned in monocitronic form under the independent T7 promoter and mRNA terminator for efficient production of flavonol glycosides. Validation of these synthetic sugar cassettes was accomplished by biotransformation of flavonols and was found to be efficient enough to achieve the production of 392.6 mg L −1 of fisetin 3-O-glucoside and 342 mg L −1 of fisetin 3-O-rhamnoside. These cassettes were able to produce similar yield with other flavonols (quercetin, kaempferol, myricetin) (Chaudhary et al., 2013; Parajuli et al., 2015) . Recently, bio-sensor plasmids have been designed to efficiently detect the flavonoid metabolites at the single cell level by engineering transcriptional regulators from Herbaspirillum seropedicae and Bacillus subtilis (Siedler et al., 2014) . Knocking down of pathways that diverge carbon from the flavonoid pathway such as fatty acid biosynthetic genes (fabD) was achieved by employing synthetic antisense RNA technology and resulted in high intracellular concentration of malonyl-CoA in E. coli. The recombinant E. coli harboring plant derived naringenin and resveratrol biosynthesis genes produced 1.70 fold higher resveratrol (268.2 mg L ) compared to the control strain lacking antisense RNA coding plasmids (Yang et al., 2015a ).
Promoter engineering
Tuning of multiple gene expression at the macroscopic level in practical applications can be achieved through promoter engineering (Alper et al., 2005) . Promoters have been used to modify gene expression for decades, especially for tuning the expression of heterologous proteins. These promoters possibly minimize the metabolic burden and allow regulation of expression at varying inducer levels in cultured cells (Lee and Keasling, 2008) . Auto inductive and inducible (beside IPTG) promoters have found extensive applications in recent years; the arabinose inducible promoter, the propionate inducible promoter, constitutive promoters, promoters induced by starvation of an essential nutrient, promoters induced upon entry into stationary phase, the effector (flavonoid) inducible promoters are all promoters to be considered for gene expression that would result in high yield production (Khlebnikov et al., 2001; Keasling, 2012; Lee and Keasling, 2008; Siedler et al., 2014) . Application of promoter engineering in flavonoid biosynthesis pathway in E. coli hosts made possible the synthesis of 100.64 mg L − 1 of naringenin from glucose (Wu et al., 2014b) , 2.3 g/l of resveratrol from p-coumaric acid (Lim et al., 2011) , 40.02 mg L − 1 of (2S)-pinocembrin from glucose (Wu et al., 2013a) and 107 mg L − 1 of eriodictyol from L-tyrosine . A hybrid cis-and trans-regulatory promoter was designed from B. subtilis, which responds to a broad concentration range of malonyl-CoA (rate limiting precursor of value-added pharmaceuticals and small molecules like flavonoids) during metabolic process, resulting in the dynamic control of malonyl-CoA associated fluxes (Xu et al., 2014) .
Ribosome binding sites
Unlike promoters, the ribosome binding sites (RBSs) are also an essential regulatory element which directly affects translation efficiency of the gene (Salis et al., 2009 ). The fundamental challenge in all kinds of metabolic engineering projects is to maximize the product yield based on the "central dogma" (transcription, translation and RNA processing) (Boyle and Silver, 2011) . Optimization of RBSs using computational approaches mediates tunable gene expression providing rational control over protein production so that bottlenecks can be identified and removed at the translational level (Salis et al., 2009; Wu et al., 2014a; Xu et al., 2012) . The RBS calculator allows the construction of customizable RBSs for a given gene sequence (Boyle and Silver, 2011; Salis et al., 2009) .
The importance of RBS engineering was shown in the expression of an artificial gene cluster containing RrPAL, ScCCL, and GeCHS that resulted in efficient gene expression and synthesis of naringenin chalcone (Hwang et al., 2003) . Enhancement in production of (−)-epicatechin achieved by using different RBSs in different constructs (Umar et al., 2012) . In a later study, after the application of synthetic sRNA modulation on metabolic engineering, combinatorial RBS optimization and promoter strength resulted in the development of an efficient E. coli strain that produced 2 g L −1 of L-tyrosine, an alternative precursor for flavonoid biosynthesis (Na et al., 2013) .
Post-modification of flavonoids
Post-modifications of natural products are usually carried out by a simple biotransformation approach using Streptomyces strains, fungal mycelia, and plant cells (Shimoda et al., 2010; Kim, 2010; da Silva and Rodrigues-Fo, 2010; Ascari et al., 2011; Wu et al., 2015) . Actinomycetes and eukaryotic cells have a wide number of natural product-modifying native enzymes. The supplementation of purified natural products, such as flavonoids, in these growing cells leads to spontaneous modification of the compounds by the cells' own available cofactor(s) and enzymes . Since this strategy of modification of natural compounds is simple and inexpensive, the approach can be scaled up to the industrial level upon optimization of the biotransformation conditions for high level production of target compounds. Importantly, the production of the desired products should be significantly high in order for the resulting process to be commercially viable. However, the drawback of this method lies with the production of a wide range of unexpected byproducts and as a result, the difficulty of purification. To minimize the side products and accomplish regioselective modification of flavonoids and other natural products, model organisms such as E. coli, Streptomyces or S. cerevisiae are engineered by introducing a partial or entire biosynthetic pathway gene clusters of intracellular co-factors/precursors along with post modification genes (Luo et al., 2015; Sun et al., 2015; Zhang et al., 2015; Kim et al., 2015a) . Exogenously supplemented compounds are biotransformed by various enzymes upon intake by the cell. Most of the post modifications of flavonoids are carried out by enzymes such as glycosyltransferases (GTs), O-methyltransferases (OMTs), cytochrome P450s (CYP), and prenyltransferases (PTs) which will be discussed herein. The selected enzymes involved in post-modification of flavonoids are highlighted in Table 4 with their sources and substrate promiscuity and nature of modification reactions. Besides these four major post-modification reactions, flavonoids are found to be modified by other diverse reactions in whole cell biotransformation while using microbial cells mainly fungi or actinomycetes. Those post-modification reactions are dehydroxylation (Lin et al., 2014) , deglycosylation (Dajanta et al., 2009; You et al., 2010; Liu et al., 2013; Lin et al., 2014) , hydrogenation (Corrêa et al., 2011; Stompor et al., 2013) , halogenation (Xiang et al., 2010) , and sulfation (Ibrahim et al., 2010; Araújo et al., 2013) . These post-modifications of flavonoids are still understudied and require extensive exploitation. Since this review is not focusing on simple biotransformation of flavonoids using plants, actinomycetes and animal cells, these modifications are not emphasized herein. Readers interested in modifications of flavonoids by simple biotransformation approach are requested to go through recent review by Cao et al. (2014) .
Glycosylation
Glycosylation, one of the most abundant post modification processes, is the process by which a sugar unit is transferred from an activated sugar nucleotide diphosphate sugar to an acceptor molecule. Moreover, glycosylation determines the chemical complexity and diversity of natural products, and brings physical as well as biological changes in the molecule (Weymouth-Wilson, 1997) . The plant and bacterial GTs that belong to GT1 family of proteins usually catalyze a direct displacement following the SN2-like mechanism (Lairson et al., 2008; Wang, 2009 ). These GTs have been used widely for the post-modification of flavonoids by engineered microbial cells. Most of the flavonoid aglycones are biotransformed to respective glycosides by E. coli having engineered nucleotide sugar pathways. The sugar pathways that have been engineered in E. coli for the production of flavonoid glycosides are presented in Fig. 6 along with the structures of the biosynthesized flavonoid glycosides. Sasaki et al. (2009) Several nucleotide sugar biosynthetic pathways are engineered in E. coli for regioselective biotransformation and high titer production of flavonoid glycosides. For example, UDP-glucose dehydrogenase (CalS8) and UDP-glucuronic acid decarboxylase (CalS9) from Micromonospora echinospora spp. calichensis were expressed together with an integrated copy of E. coli glucose-1-phosphate uridylyltransferase (galU) in the background strain E. coli BL21(DE3) deficient of glucose phosphate isomerase (pgi) for excess intracellular availability of UDP-xylose along with 7-Oglycosyltransferase (ArGt-4) from A. thaliana. The engineered strain was fed with naringenin to produce naringenin 7-O-xyloside (Simkhada et al., 2009 ). More recently, quercetin 3-O-xyloside (42.5 mg L −1 ) has been solely produced by biotransformation of quercetin in E. coli with an engineered UDP-α-D-glucose pathway in which glucose-6-phosphate utilizing pathway genes such as pgi, glucose-6-phosphate Fig. 6 . Biosynthetic pathways of different NDP-sugars reconstituted in E. coli for the production of natural/un-natural flavonoid glycosides. Glucose-1-phosphate is the branch point for the biosynthesis of TDP-sugars and UDP-sugars. Thymidylyltransferase (tgs) transfers TDP from TTP whereas uridylyltransferase (galU) transfers UDP to glucose-1-phosphate to produce TDP-α-D-glucose and UDP-α-D-glucose, respectively. Further modifications of TDP-α-D-glucose and UDP-α-D-glucose by diverse enzymes result in production of various NDP-sugars. Yellow arrows represent reactions leading to diverse flavonoid glycoside structures produced using intracellular pool of NDP-sugars. Highlighted in green are the sugar units. Highlighted in red are deletion gene targets and in blue overexpression gene targets for production of various NDP-sugars. Gene abbreviations are as follows: glf: glucose facilitator diffusion protein; glk: glucokinase; pgm: phosphoglucomutase; tgs/rfbA: glucose 1-phosphate thymidylyltransferase; dh/rfbB: TDP-glucose 4, 6-dehydratase; fdtA: dTDP-6-deoxy-D-hex-4-ulose isomerase; fdtB: TDP-6-deoxy-D-galactose 3-aminotransferase; gerF: gerK1: epi/rfbC: TDP-4-keto-6-deoxyglucose 3, 5-epimerase; gerB:TDP-6-deoxy-D-glucose 4-aminotransferase; wecE: TDP-6-deoxy-D-galactose 4-aminotransferase; kr/rfbD: dTDP-4-dehydrorahmnose reductase; tll: dTDP-6-deoxy-L-lyxo-4-hexulose reductase; rffA: dTDP-4-oxo-6-deoxy-Dglucose transaminase; galU: glucose 1-phosphate uridylyltransferase; ushA: UDP--D-glucose hydrolase; uge: UDP-glucose epimerase; calS8/ugd: UDP-glucose 6-dehydrogenase; calS9: UDP-glucuronic acid decarboxylase; uxs: UDP-xylose synthase; uxe: UDP-xylose epimerase; arnA: UDP-4-amino-4-deoxy-L-arabinose (L-Ara4N) formyltransferase/UDP-glucuronic acid C-4″-decarboxylase; arnB: UDP-L-Ara4-O-C-4″ transaminase; pgi: glucose phosphate isomerase; zwf: D-glucose-6-phosphate dehydrogenase; glmS: L-glutamine:D-fructose-6-phosphate aminotransferase; glmM: phosphoglucosamine mutase; glmU: glucosamine-1-phosphate acetyltransferase; ArGT-3: flavonol 3-O-glycosyltransferase; AtUGT78D1: UGT78K1: flavonol 3-O-glucosyltransferase; AtUGT78D3: flavonol 3-O-glycosyltransferase; VvUGT: flavonoid UDP-glucuronosyltransferase; PhUGT: flavonoid UDP-galactosyltransferase; AtUGT78D2: flavonol 3-O-glycosyltransferase.
1-dehydrogenase (zwf), and UDP-α-D-glucose hydrolase (ushA) were blocked and the entire UDP-xylose biosynthetic pathway genes from glucose-1-phosphate were overexpressed (Pandey et al., 2013b) . Han et al. (2014) also synthesized the same product to a higher scale of 150 mg L − 1 by overexpressing UDP-xylose synthase (uxs), UDPglucose 6-dehydrogenase (ugd), and A. thaliana AtUGT78D3 in a UDP-4-amino-4-deoxy-L-arabinose (L-Ara4N) formyltransferase/UDP-glucuronic acid C-4″-decarboxylase (arnA) deleted E. coli mutant. Similarly, the pools of TDP-L-rhamnose and TDP-D-allose sugars were developed separately by expressing the respective sugar biosynthetic pathway genes from different bacterial sources in the pgi-deleted E. coli BL21 (DE3). The recombinant strains overexpressing additional A. thaliana GT (ArGt-3) were able to biotransform both quercetin and kaempferol to 3-O-rhamosyl quercetin (24 mg L −1
) and 3-O-rhamnosyl kaempferol (12.9 mg L − 1 ), while 3-O-allosyl quercetin was produced in trace amount (Simkhada et al., 2010) . In another similar recent report, E. coli BL21 (DE3) carrying three genes, ugd, arnA, and arnB (UDP-LAra4-O-C-4″ transaminase) along with glycosyltransferase AtUGT78D3 from A. thaliana, produced quercetin-
) from quercetin (Kim et al., 2010a) . Other examples of biotransformation of aglycones to glycosides using a similar nucleotide sugar pathway engineering approach in E. coli include production of quercetin 3-O-N-acetylglucosamine (380 mg L ) were also produced using two different combinations of three GTs . Recently, we have also produced kaempferol 3-O-glucoside (109.3 mg L − 1 ) from naringenin by introducing naringenin modifying genes (AtF3H and AtFLS1 from A. thaliana) and UDP-α-D-glucose pathway genes overexpressing background strain of E. coli BL21(DE3)/ΔpgiΔzwfΔushA (Malla et al., 2013) . Moreover, a newly constructed E. coli BL21(DE3)/ ΔpgiΔzwfΔgalU mutant was engineered to generate three different dTDP-amino-deoxy sugars (dTDP-4,6 dideoxy 4-amino-D-galactose, dTDP-4,6 dideoxy 4-amino-D-glucose, and dTDP-3,6 dideoxy 3-amino-D-galactose) by overexpressing dTDP 4-keto 4,6-dideoxy glucose intermediate modifying sugar aminotransferases from various sources. Over expression of an A. thaliana GT transferred 4,6 dideoxy 4-amino-D-galactose and 3,6 dideoxy 3-amino-D-galactose sugar moieties to 3-OH of exogenously supplemented quercetin and kaempferol. Altogether, four novel flavonols with four novel conjugated aminodeoxy sugars were successfully generated by this biotransformation approach . In our recent report , we produced glucoside and rhamnoside derivatives of fisetin by engineering respective sugar pathway genes in a mono-cistronic fashion. This approach of biotransformation resulted in significantly higher titers of target sugar conjugated fisetin glycosides in which 392.6 mg L ), baicalein-7-Oglucoside (33.19 mg L −1 ) have also been produced using Arabidopsis
GTs in UDP-α-D-glucose-producing engineered E. coli cells (Thuan et al., 2013a (Thuan et al., , 2013b . Using the same strain that over-produces UDP-α-D-glucose, and also expressing isoflavonoid specific GT (GmIF7GT), and 6′′-O-malonyltransferase (GmIF7MaT) from G. ) were produced by feeding genistein and daidzein aglycones (Koirala et al., 2014a) . Similarly, the use of a GT from B. licheniformis (YjiC), Pandey et al. (2014a) produced several glucosides of genistein, daidzein, formononetin, and biochanin A (Fig. 6 ). Glucoside derivatives of flavonoids have also been produced by using E. coli cells harboring only GT without engineering UDP-glucose biosynthesis pathway genes. For example, diverse quercetin glucosides (quercetin 3-O-glucoside, quercetin 7-O-glucoside, quercetin 3′-O-glucoside, and quercetin 4′-O-glucoside) have been produced by simple biotransformation of quercetin using E. coli cells harboring different Arabidopsis GTs (Lim et al., 2004) . Similar approaches were also used by other groups to produce kaempferol 3-O-glucoside (44.8 mg L )) were also produced using an E. coli/Δpgi Δzwf ΔushA harboring YjiC (Fig. 7) .
Methylation
Methylation is another common post modification of many secondary metabolites. Plant originated secondary metabolites, especially flavonoids, are methylated by S-adenosyl-L-methionine (SAM)-dependent caffeoyl-CoA O-methyltransferases (OMTs). However, a few of the microbial originated SAM-dependent OMTs are also found to methylate plant flavonoids. In this section, microbial biotransformation of flavonoids using engineered E. coli, yeast, and Streptomyces to methylated derivatives will be discussed.
A G. max originated O-methyltransferase (SOMT-2) was functionally overexpressed in E. coli and used for the biotransformation of various exogenously added flavonoids (apigenin, naringenin, and quercetin) and isoflavonoids (daidzein, geninstein) which were stoichiometically converted to 4′-O-methylated derivatives (Kim et al., 2005a) . By using poplar OMT (POMT-7), Ahn and his group biotransformed a range of flavonoids, including flavonols (quercetin, kaempferol, isorhamnetin), flavones (apigenin, luteolin), and flavanone (eriodictyol, naringenin) to produce respective 7-O-methylated derivatives (Kim et al., 2006a) . The same group also studied co-expression of two regiospecific OMTs, rice originated ROMT-9 and SOMT-2 in E. coli and produced regiospecifically methylated 3′-methylated and the 3′,4′-dimethylated quercetin derivatives (Kim et al., 2005b) . A similar approach of coexpression of two previously characterized regioselective OMTs, POMT-7 regiospecific for 7-OH and ROMT-9 regiospecific for 3′-OH was used for biotransformation of flavonoids in E. coli. The recombinant strain was fed with flavonoids (quercetin, and luteolin) for production of specific compounds; however a mixture of multiple methylated compounds was produced. For example, 3′ and 4′ methylated derivatives of luteolin (3′-O-methyl luteolin, 3′,4′-O-dimethylluteolin, 7,3′-Odimethylluteolin, and 7,3′,4′-O-trimethylluteolin) and quercetin (3′-Omethylquercetin, 3′,4′-O-dimethylquercetin, 7,3′-O-dimethylquercetin, and 7, 3′,4′-O-trimethylquercetin) (Fig. 8) were all produced in the biotransformation reaction mixture altering the regioselectivity of POMT-7 from 7-to the 4′-OH groups (Kim et al., 2008) .
Beside plant OMTs, Streptomyces derived OMTs were also used for the biotransformation of flavonoids. An OMT from S. avermitilis MA-4680 (SaOMT-2) was expressed in E. coli. The recombinant strain was able to transfer a methyl group regiospecifically at the 7-OH group of isoflavones (daidzein, genistein), flavonols (kaempferol, quercetin, isorhamnetin), flavones (apigenin), and flavanones (naringenin) (Kim et al., 2006b ). Another OMT from S. peucetius ATCC 27952 (SpOMT2884) was also functionally overexpressed in E. coli and used for the biotransformation of various flavonoids such as flavones (7,8-dihydroxyflavone, luteolin) , flavonols (quercetin, rutin), flavanones (naringenin), and isoflavonoids (daidzein, formononetin). One preferred substrate, 7,8-dihydroxyflavone was converted to 7-hydroxy-8-methoxyflavone at relatively higher rate. Optimization of substrate concentration, time, media parameters and scale-up using a 3-L fermentor produced 52.57 mg L − 1 of 7-hydroxy-8-methoxyflavone from 200 μM of 7, 8-dihydroxyflavone within 12 h .
Hydroxylation
Hydroxylation of flavonoids is also an important post modification for the biosynthesis of a diverse array of flavonoids. In order to generate diversity in structural chemistry of flavonoids and to produce novel therapeutically or neutraceutically important compounds, flavonoids are hydroxylated by various microbial biotransformation approaches. However, very limited studies have been carried out to produce hydroxylated derivatives of flavonoids using microbial systems. Whole cell biotransformation of daidzein, one of the phytoestrogen isoflavones, using Nocardia farcinica IFM 10152 resulted in production of 3′,4′,7-trihydroxyisoflavone, 4′,6,7-trihydroxyisoflavone, and 4′,7,8-trihydroxyisoflavone . Moreover, the study identified two key cytochrome P450 (CYP450) monoxygenases (nfa12130 and nfa33880) with their native ferredoxins and ferredoxin reductase partner responsible for the hydroxylation among 27 different CYP450s. The recombinant E. coli expressing the same set of CYPs was also able to produce some of the hydroxylated derivatives of daidzein (Choi et al., 2009) . A similar approach of whole cell biotransformation of two isoflavones (daidzein and genistein) was carried out using S. avermitilis MS-4680. The strain biotransformed daidzein to 3′,4′,7-trihydroxyisoflavone and genistein to 3′,4′,5,7-tetrahydroxyisoflavone by regiospecifically hydroxylating at the ortho-position with an average of 16% molar conversion yield after 24 h of reaction (Roh et al., 2009a) .
A recombinant E. coli strain, constructed by overexpressing the B. subtilis 168 CYP107H1 along with putidaredoxin reductase (camA) and putidaredoxin (camB) from Pseudomonas putida as the redox partners, hydroxylated exogenously fed daidzein regiospecifically at 3′-ortho-position to yield 7,3′,4′-trihydroxyisoflavone (Fig. 8) . However, the conversion yield was relatively small (0.6%) (Roh et al., 2009b) . The same group also used S. avermitils MA4680 as an expression host for the expression of CYP107Y1 (SAV2377), CYP125A2 (SAV5841) and CYP107P2 (SAV4539) originally derived from the same strain. The recombinant S. avermitilis strains overexpressing CYP107Y1, CYP125A2, and CYP107P2 biotransformed genistein, chrysin and apigenin to 3′,4′,5,7,-tetrahydroxyisoflavone, B-ring hydroxylated 5,7-dihydroxyflavone and 3′,4′,5,7,-tetrahydroxyflavone, respectively. The molar conversion was 25% for genistein, 12% for chrysin, and 10% for apigenin. E. coli expressing the same enzymes Fig. 7 . Structures of glucosides of flavonoids produced after biotransformation using E. coli cells harboring GT. Blue colored GTs were used as enzymes for production of target glucosides. The details of genes used are explained in the text. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) with P. putida redox partners (PdR/Pdx) also transformed the same set of flavonoids with 3-4 fold lower conversion rate (Pandey et al., 2011) .
Prenylation
Prenylated flavonoids, conjugated with lipophilic prenyl side-chain (5-carbon (dimethylallyl), 10-carbon (geranyl) or 15-carbon (farnesyl) have low abundance in nature. They have many applications as nutraceuticals and pharmaceuticals, however their chemical synthesis is tedious with limited production yield (Botta et al., 2005a) . Thus, microbial biotransformation is used for the production of prenylated derivatives using prenyltrnasferases (PTs) from various sources (Botta et al., 2005b) . A thorough recent review covering the topic of prenylated flavonoids and their importance and biological activities has recently been published by Yang et al. (2015b) . Most of the prenylated flavonoids are produced by biotransformation using plant and fungal whole cells. Use of engineered microbial cells for production of prenylated flavonoids has not yet been explored.
A PT (Orf2) from Streptomyces sp. strain CL190 was identified to transfer the geranyl group to various flavonoid compounds such as daidzein, formononetin, genistein, fisetin, naringenin, and resveratrol (Kuzuyama et al., 2005) . The same Orf2 (renamed NphB) and SCO7190, a NphB homolog from S. coelicolor A3(2) was used for the chemoenzymatic synthesis of various prenylated flavonoids (Kumano et al., 2008) . Similarly, another PT from Streptomyces niveus, NovQ was also characterized to transfer dimethylallyl group to phenylpropanoids and B-ring of flavonoids (Ozaki et al., 2009 ). However, none of these enzymes was used for in vivo production of prenylated flavonoids. A naringenin 8-dimethylallyltransferase (SfN8DT-1) from Sophora flavescens which transfers a prenyl group at the 8-position of naringenin was expressed in yeast strain W303-1 A that was deficient in coenzyme Q2 4-hydroxybenzoate polyprenyltransferase (COQ2) (Fig. 8) . The transgenic yeast strain produced a maximum of 566 μg L − 1 of 8- dimethylallyl naringenin from exogenously added 0.2 mM naringenin (Sasaki et al., 2009 ).
Conclusions
Flavonoids are ubiquitous in the plant kingdom, have diverse chemical structures, and their applications in human health have been widely studied. The biosynthetic pathways of flavonoids have also been intensively studied and characterized to define the role and mechanism of each gene involved. Moreover, a large number of flavonoids have been identified and continue to be isolated from plants (Veitch and Grayer, 2011) , some of which are recognized as potential lead compounds for onset of diseases (https://clinicaltrials.gov/; Xiao et al., 2014) . In addition, the flavonoids and their derivatives have also been broadly used in functional foods, nutraceuticals, and cosmetics. The current market of flavonoids is dependent upon availability of their plant sources, which is affected by seasonal variations and involves costly, inefficient, and environmentally unfriendly extraction processes. Thus, implanting heterologous plant flavonoid biosynthesis pathways in microbial hosts is an alternative method of production. Application of recent molecular biology and system/synthetic biology tools has created the potential for the biosynthesis of a multitude of flavonoids and unnatural derivatives from genetically tractable microbial hosts such as E. coli, Streptomyces and S. cerevisiae. However, low microbial production titer yields of flavonoids from cheap carbon sources is one of the limiting factors for industrial scale-up and commercial production of flavonoids using recombinant microbial cells. The identification of bottlenecks, fine tuning/optimization of flavonoid biosynthetic pathways, and simultaneous balance of metabolic fluxes by rewiring native precursors/cofactors biosynthesis pathways of host organisms are still challenging. Nevertheless, combined application of metabolic engineering and system/synthetic biology tools for strain-design, construction and optimization may address the hurdles of inefficient production of flavonoids from microbes.
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